SLIDE 1 Oxygen saturation target ranges and alarm settings for very immature infants
Barbara Schmidt, MD, MSc, CM
SLIDE 2 Outline
- Design and main results of the Canadian
Oxygen Trial (COT)
- IPD Meta-analysis of COT, SUPPORT
and the 3 BOOST trials
- Saturation target ranges vs alarms
- Which target ranges and alarms are right
for your patients?
SLIDE 3 Barbara Schmidt, Robin Whyte, Elizabeth Asztalos, Diane Moddemann, Christian Poets, Yacov Rabi, Alfonso Solimano, Robin Roberts and The COT Investigators
SLIDE 4 Main COT Study Question
P I C O T In infants born at 23 0/7 to 27 6/7 wk, does a target saturation of 85-89% compared with 91-95% increase or decrease the risk of death
- r neurosensory disability
at a corrected age of 18 months?
SLIDE 5 Target range for displayed saturations
- n off-set pulse oximeters: 88-92%
Low target range for true saturations: 85-89% High target range for true saturations: 91-95%
SLIDE 6
Death or Disability at 18 Months
85-89% 91-95%
283 of 569 49.7%
OR = 1.08 95% CI 0.85-1.37 p = .52
298 of 578 51.6%
SLIDE 7 Components of Primary Outcome
85-89% 91-95% OR (95%CI)
Death 16.6% 15.3% 1.1 (0.8-1.5) GMFCS ≥2 6.1% 6.4% 1.0 (0.6-1.7)
Bayley III < 85
40% 40% 1.0 (0.8-1.3) Deafness 3.7% 2.5% 1.5 (0.7-3.2) Blindness 1.0% 0.6% 1.7 (0.4-7.1)
SLIDE 8
Secondary Outcomes
85-89% 91-95% P-value
Severe ROP 12.8% 13.1% .80 NEC 12.3% 9.3% .10
Targeting lower saturations reduced the PMA at last use of oxygen therapy by 0.8 weeks; 95% CI -1.5 to -0.1; P=.03
SLIDE 9 COT Conclusions
Targeting oxygen saturations of 85-89% as compared with 91-95% had no significant effect on rates of
- death or disability at 18 months
- death before 18 months
- necrotizing enterocolitis
- severe retinopathy of prematurity
SLIDE 10 Outline
- Design and main results of the
Canadian Oxygen Trial (COT)
- Meta-analysis of COT, SUPPORT and
the 3 BOOST trials
- Saturation target ranges vs alarms
- Which target ranges and alarms are
right for your patients?
SLIDE 11 Effects of Targeting Lower Saturations Trial
Death before Follow-up Severe ROP
SUPPORT
↓↓
BOOST NZ No Diff No Diff BOOST AU No Diff No Diff BOOST UK No Diff No Diff COT No Diff No Diff
SLIDE 12 JAMA 2018; 319:2190-2201
SLIDE 13 Main NeOProM Results
SpO2 85-89% SpO2 91-95% Adjusted RR (95%CI) P- value Risk Difference Primary
53.5% 51.6% 1.04 (0.98, 1.09) 0.21 Major disability 40.5% 40.5% 1.00 (0.93, 1.08) 0.97 Death 19.9% 17.1% 1.17 (1.04, 1.31) 0.01 2.8% Severe NEC 9.2% 6.9% 1.33 (1.10, 1.61) 0.003 2.3% ROP treatment 10.9% 14.9% 0.74 (0.63, 0.86) <0.001 4.0%
This IPD meta-analysis is an important achievement but has delivered no surprises!
SLIDE 14
SLIDE 15 AAP Conclusion
Recent RCTs suggest that a targeted
- xygen saturation range of 90% to
95% may be safer than 85% to 89%, at least for some infants. However, the ideal oxygen saturation range for extremely low birth weight infants remains unknown.
SLIDE 16 “We detected 40 different SpO2 ranges, and even the most frequently reported range (i.e., 90–95%) was used in only 28% of the 193 respondent NICUs.”
Survey conducted Nov 2015 to Feb 2016
SLIDE 17 NeOProM Intervention
Alarm settings? Compliance with alarm settings? Impact of reversal from off-set to true saturations? Response to alarms? Duration of targeting? Transfusion policies?
SLIDE 18 Outline
- Design and main results of the
Canadian Oxygen Trial (COT)
- Meta-analysis of COT, SUPPORT and
the 3 BOOST trials
- Saturation target ranges vs alarms
- Which target ranges and alarms are
right for your patients?
SLIDE 19
Target ranges are not alarm settings
SLIDE 20
Protocol-prescribed alarm settings after conversion to true SpO2
SLIDE 21 Goal of Oxygen SaturationTargeting
“Providers need to understand that
cumulative oxygen saturations
- ver time represent a bell shaped
curve, and the role of the health care team is to minimize the tails in both directions”.
Greenspan and Goldsmith, Pediatrics 2006; 118:1741
SLIDE 22 JAMA 2015;314:595-603
Intermittent Hypoxemia and Late Death or Disability
SLIDE 23 JAMA 2015;314:595-603
Intermittent Hypoxemia and Motor Impairment
SLIDE 24
AAP Conclusion
Alarm limits are used to avoid potentially harmful extremes of hyperoxemia or hypoxemia. Given the limitations of pulse oximetry and the uncertainty that remains regarding the ideal oxygen saturation target range for infants of extremely low birth weight, these alarm limits could be fairly wide.
SLIDE 25
AAP Conclusion
Regardless of the chosen target, an upper alarm limit approximately 95% while the infant remains on supplemental oxygen is reasonable.
SLIDE 26 AAP Conclusion
A lower alarm limit will generally need to extend somewhat below the lower target, as it must take into account practical and clinical considerations, as well as the steepness of the
- xygen saturation curve at lower
saturations.
SLIDE 27 Outline
- Design and main results of the
Canadian Oxygen Trial (COT)
- Meta-analysis of COT, SUPPORT and
the 3 BOOST trials
- Saturation target ranges vs alarms
- Which target ranges and alarms are
right for your patients?
SLIDE 28 Outcome Rates Differ Between Trials
Trial
Death before Follow up Severe ROP SUPPORT 20.1% 13.4% BOOST NZ 15.3% 7.5% BOOST AU 16.7% 7.7% BOOST UK 22.8% 19.2% COT 15.9% 12.9%
SLIDE 29
NeOProM
Outcome NNT NNH Mortality 36 Severe NEC 44 Treated ROP 25
Number needed to treat (NNT) or harm (NNH) with higher saturation target range:
SLIDE 30
Absolute effects of higher targeting will depend on our patients’ baseline risks Example: Mortality
Baseline Risk Absolute Risk Reduction NN Treat 20% 2.8% 36 10% 1.4% 71 5% 0.7% 143
SLIDE 31 An example from a Canadian NICU
Outcome Rate NNT NNH Mortality 9% 77 Surgical NEC 4% 100 Severe ROP 13% 21
Our oximeter alarms have been set at 85% and 95% for many years. Why should we change them?
SLIDE 32